MEZIGDOMIDE: 28 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
28
Total FAERS Reports
4 (14.3%)
Deaths Reported
18
Hospitalizations
28
As Primary/Secondary Suspect
8
Life-Threatening
First Report: 20201012 · Latest Report: 20240807
What Are the Most Common MEZIGDOMIDE Side Effects?
#1 Most Reported
Pneumonia
11 reports (39.3%)
#2 Most Reported
Infection
11 reports (39.3%)
#3 Most Reported
Covid-19
10 reports (35.7%)
All MEZIGDOMIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Infection | 11 | 39.3% | 2 | 7 |
| Pneumonia | 11 | 39.3% | 2 | 8 |
| Covid-19 | 10 | 35.7% | 2 | 8 |
| Off label use | 8 | 28.6% | 1 | 6 |
| Plasma cell myeloma refractory | 7 | 25.0% | 1 | 6 |
| Delirium | 6 | 21.4% | 0 | 6 |
| Neutropenia | 6 | 21.4% | 2 | 1 |
| Pyrexia | 6 | 21.4% | 0 | 6 |
Who Reports MEZIGDOMIDE Side Effects? Age & Gender Data
Gender: 47.1% female, 52.9% male. Average age: 71.3 years. Most reports from: AU. View detailed demographics →
Is MEZIGDOMIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2020 | 1 | 1 | 1 |
| 2021 | 7 | 0 | 6 |
| 2023 | 7 | 1 | 6 |
| 2024 | 3 | 0 | 3 |
What Is MEZIGDOMIDE Used For?
| Indication | Reports |
|---|---|
| Plasma cell myeloma | 18 |
| Plasma cell myeloma refractory | 10 |
Official FDA Label for MEZIGDOMIDE
Official prescribing information from the FDA-approved drug label.